Expert Review of Pharmacoeconomics & Outcomes Research, Volume 24, Issue 5 (2024)

Browse this journal

Expert Review of Pharmacoeconomics & Outcomes Research, Volume 24, Issue 5 (2024)

See all volumes and issues
Volume 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Vol 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Foreword

Editorial
Expert review of pharmacoeconomics and outcomes research: high impact articles from 2023
Mickaël Hiligsmann, Mitchell P. DeKoven, Riddhi Doshi, Carolyn Gotay, Carlo Lazzaro, Jayashri Sankaranarayanan & Rayya Hajjar
Pages: 577-579
Published online: 09 Apr 2024
First Page PreviewforExpert review of pharmacoeconomics and outcomes research: high impact articles from 2023 | Full Text | References | PDF (163.1 KB) | EPUB
  • 452 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Editorial

Editorial
Incorporating public and wider stakeholder views in the design of health state valuation studies in adults and young people: an undervalued resource?
Philip A. Powell
Pages: 581-584
Published online: 25 Mar 2024
First Page PreviewforIncorporating public and wider stakeholder views in the design of health state valuation studies in adults and young people: an undervalued resource? | Full Text | References | PDF (212.5 KB) | EPUB
  • 160 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Learnings from cross-border biosimilar pricing policies in Europe
Steven Simoens, Teresa Barcina Lacosta & András Inotai
Pages: 585-588
Published online: 26 Mar 2024
First Page PreviewforLearnings from cross-border biosimilar pricing policies in Europe | Full Text | References | PDF (155.8 KB) | EPUB
  • 384 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Review

Review Article
Cost effectiveness of hepatitis C direct acting agents
Akshay Shetty, Michelle Lee, Julia Valenzuela & Sammy Saab
Pages: 589-597
Published online: 03 May 2024
AbstractforCost effectiveness of hepatitis C direct acting agents | Full Text | References | PDF (503.6 KB) | EPUB
  • 39 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Informing evidence-based medicine for opioid use disorder using pharmacoeconomic studies
Ali Jalali
Pages: 599-611
Published online: 09 May 2024
AbstractforInforming evidence-based medicine for opioid use disorder using pharmacoeconomic studies | Full Text | References | PDF (345.4 KB) | EPUB
  • 82 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Quality-adjusted life years for HER2-positive, early-stage breast cancer using trastuzumab-containing regimens in the context of cost-effectiveness studies: a systematic review
Sudewi Mukaromah Khoirunnisa, Fithria Dyah Ayu Suryanegara, Didik Setiawan & Maarten Jacobus Postma
Pages: 613-629
Published online: 20 May 2024
AbstractforQuality-adjusted life years for HER2-positive, early-stage breast cancer using trastuzumab-containing regimens in the context of cost-effectiveness studies: a systematic review | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 186 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Original Research

Article
Cost-effectiveness analysis of atezolizumab plus bevacizumab compared with sorafenib as first-line treatment in advanced hepatocellular carcinoma in Singapore
Cheng Ean Chee, Jasmeet Singh Khara, John Cheong, Jek Fong, Sivabalan Sivanesan, Jian Yi Choy, Meibo Hu, Amrita Viswambaram & Han Chong Toh
Pages: 631-641
Published online: 22 May 2024
AbstractforCost-effectiveness analysis of atezolizumab plus bevacizumab compared with sorafenib as first-line treatment in advanced hepatocellular carcinoma in Singapore | Full Text | References | PDF (466.1 KB) | EPUB
  • 15 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Health-related quality of life measured using the EQ-5D-3L: iranian population norms
Abdoreza Mousavi, Ali Akbari Sari, Fakhraddin Daastari & Rajabali Daroudi
Pages: 643-651
Published online: 12 Mar 2024
AbstractforHealth-related quality of life measured using the EQ-5D-3L: iranian population norms | Full Text | References | PDF (626.8 KB) | EPUB
  • 50 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Economic value of toripalimab plus axitinib as first-line treatment for advanced renal cell carcinoma in China: a model-based cost-effectiveness analysis
Shuo Kang & Jintuo Yin
Pages: 653-659
Published online: 21 Mar 2024
AbstractforEconomic value of toripalimab plus axitinib as first-line treatment for advanced renal cell carcinoma in China: a model-based cost-effectiveness analysis | Full Text | References | PDF (774.3 KB) | EPUB | Supplemental
  • 63 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Economic burden of type-2 diabetes in Peru: a cost-of-illness study valuing cost differences associated with the level of glycemic control
Janice Seinfeld, Alfredo Sobrevilla, María Laura Rosales, Mauricio Ibáñez, Delia Ruiz, Eduardo Penny & Sergio Londoño
Pages: 661-669
Published online: 08 Apr 2024
AbstractforEconomic burden of type-2 diabetes in Peru: a cost-of-illness study valuing cost differences associated with the level of glycemic control | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 751 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access
Article
Cost-utility of sintilimab plus chemotherapy vs chemotherapy as first-line treatment of advanced gastric or gastroesophageal junction cancer in China
Wei Li & Li Wan
Pages: 671-678
Published online: 11 Apr 2024
AbstractforCost-utility of sintilimab plus chemotherapy vs chemotherapy as first-line treatment of advanced gastric or gastroesophageal junction cancer in China | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 41 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
Monetary valuation of one year in full capability and health based on demographics, health status, income and well-being
Mabore Thema, Zsuzsanna Beretzky & Valentin Brodszky
Pages: 679-686
Published online: 29 Apr 2024
AbstractforMonetary valuation of one year in full capability and health based on demographics, health status, income and well-being | Full Text | References | PDF (355.7 KB) | EPUB
  • 23 Views
  • 0 CrossRef citations
  • 0Altmetric
Article
A cost analysis of a simplified model for HCV screening and treatment at a tertiary hospital in Zimbabwe
Blessing Dzingirai, Leolin Katsidzira, Vongai Mwanesani, Maarten Jacobus Postma, Marinus van Hulst & Nyashadzaishe Mafirakureva
Pages: 687-695
Published online: 08 May 2024
AbstractforA cost analysis of a simplified model for HCV screening and treatment at a tertiary hospital in Zimbabwe | Full Text | References | PDF (709.6 KB) | EPUB | Supplemental
  • 145 Views
  • 0 CrossRef citations
  • 0Altmetric
Open Access

Explore articles